SCHEMBL32670482

SCHEMBL32670482

CC(C)N(C)c1ccc(CO)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ CA1 P00915 3/20 0.38
▸ CA2 P00918 3/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA4 P22748 1/20 0.38
▸ CA6 P23280 1/20 0.38
▸ CA5A P35218 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CA14 Q9ULX7 1/20 0.38
▸ CA5B Q9Y2D0 1/20 0.38
▸ S1PR1 P21453 1/20 0.36
▸ NOS3 P29474 1/20 0.35
▸ NOS1 P29475 1/20 0.35
▸ NR1I2 O75469 1/20 0.35
▸ PRSS1 P07477 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18279459 0.82 ALDH1A1 (0.58) TSHRALDH1A1CYP3A4MAPK1TDP1
SCHEMBL20323571 0.80 HPGD (0.41) TSHRALDH1A1CYP3A4MAPK1TDP1
SCHEMBL27404004 0.78 KEAP1 (0.44) TSHRALDH1A1CYP3A4MAPK1TDP1
SCHEMBL22702644 0.78 ALDH1A1 (0.42) TSHRALDH1A1ADRB3PTGS2
SCHEMBL18032884 0.78 ACHE (0.36) S1PR1
SCHEMBL11310810 0.77 TSHR (0.44) TSHRALDH1A1CYP3A4MAPK1TDP1
SCHEMBL165131 0.77 ALDH1A1 (0.64) TSHRALDH1A1CYP3A4MAPK1TDP1
SCHEMBL15014089 0.76 S1PR1 (0.44) TSHRS1PR1PRSS1PRSS2PRSS3
SCHEMBL21566931 0.75 ESR1 (0.47) TSHRALDH1A1CYP3A4MAPK1TDP1
SCHEMBL22388178 0.75 KDM4E (0.39) TSHRALDH1A1CYP3A4MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035364-A1 BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2026-02-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035364-A1 BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES SCN1B, SCN2B, SCN11A TSHR 420/4885ALDH1A1 760/4885CYP3A4 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback